GL Pharm Tech (XKRX:204840) Debt-to-Asset : 0.36 (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is GL Pharm Tech Debt-to-Asset?

GL Pharm Tech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩8,170 Mil. GL Pharm Tech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩6,489 Mil. GL Pharm Tech's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₩40,837 Mil. GL Pharm Tech's debt to asset for the quarter that ended in Sep. 2024 was 0.36.

GL Pharm Tech Debt-to-Asset Historical Data

The historical data trend for GL Pharm Tech's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GL Pharm Tech Debt-to-Asset Chart

GL Pharm Tech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.59

0.37

0.25

0.34

0.45

GL Pharm Tech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.42	0.45	0.36	0.36	0.36

Competitive Comparison of GL Pharm Tech's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, GL Pharm Tech's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GL Pharm Tech's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GL Pharm Tech's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where GL Pharm Tech's Debt-to-Asset falls into.

GL Pharm Tech Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

GL Pharm Tech's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(6458.012	+	11327.316)	/	39868.265
	=	0.45

GL Pharm Tech's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(8170.13	+	6488.576)	/	40836.929
	=	0.36

GL Pharm Tech (XKRX:204840) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

GL Pharm Tech Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of GL Pharm Tech's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

GL Pharm Tech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GL Pharm Tech Corp (XKRX:204840) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

137, Sagimakgol-ro, Jungwon-gu, No 714 Jungang Induspia V, Gyeonggi-do, Seongnam, KOR, 462713

Website

http://www.glpt.co.kr

GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. It offers products including Incrementally Modified Drugs, Generic Drug and G-SOREN Tab. It also provides generic drugs for cardiovascular, gastric, diabetes, CNS, and respiratory diseases.

GL Pharm Tech Headlines

No Headlines